In a wide-ranging and forthcoming interview, Eric Schmidt, the former Google CEO who helped steer the tech giant’s foray into health care, opened up about a host of issues facing the future of medicine.
Among the topics Schmidt touched on in a half-hour conversation at the STAT Health Tech Summit: his upcoming role as the board chair of the powerful Broad Institute, why synthetic biology is a critical field to watch, the fraught debate over patient data privacy and health systems, and why Boston should double down on investing in the life sciences.
